Pruritus relief is the greatest treatment priority for those with moderate to severe AD, despite variations in priorities across patient subgroups.

Delgocitinib cream has a significant dose-response relationship for achieving 75% improvement in EASI among patients with AD at 8 weeks.

More than 3600 bottles of Thyroid Tablets, USP 30 mg were recalled nationwide after lab tests showed the pills may be too strong.

Socrodeucitinib significantly reduced PASI scores at 12 weeks of treatment among adults with moderate to severe plaque psoriasis.

Topical therapies may offer more favorable tolerability profiles than ablative treatments for immunocompetent adults with external anogenital warts.

A survey of US adults shows widespread endorsement of outdated beliefs regarding antibiotic treatment duration and adherence.

Nearly 40,000 bottles of widely sold eye drops are being pulled from shelves because the maker cannot guarantee the product is sterile.

Though laboratory abnormalities are common with ritlecitinib therapy for alopecia areata, the majority are mild and not clinically significant.

Cellular grafting with ReCell results in superior repigmentation compared with standard tissue grafting in select populations ...

No significant differences were noted in the biophysical characteristics of the scalp in women who used hijab vs those who did not.

The use of hair growth nutraceuticals was associated with significant improvements across various measures of hair growth in ...

Monoethyl phthalate exposure in pregnancy is associated with elevated systolic and diastolic blood pressure levels.